In addition to attending the J-Labs Singapore Family Office Investor Event, he will be in Singapore from September 14-17 for additional meetings with collaborators in
Pepticom Ltd. is proud to be a virtual member company of Johnson & Johnson‘s global incubator network, JLABS, in EMEA and Singapore. JLABS is the
Join our CEO, Immanuel Lerner for insights on AI-driven peptide drug discovery:📅 March 12:🗝 Keynote – Orally Available Peptides | 9:55 AM💡 Panel – Novel
Pepticom have successfully closed a $6.6 million Series A1 funding round, spearheaded by Japan Israel High Tech Ventures 2 LP, to revolutionize the landscape of
Join them at the J.P. Morgan 43rd Annual Healthcare Conference 2025, which will take place 13-16 January 2025 in San Francisco, CA, USA.Mr. Lerner will